Vitamin e derivative tested as Parkinson's slowing agent in new trial
NCT ID NCT04491383
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily dose of tocotrienols (a type of vitamin E) can slow the worsening of motor symptoms in Parkinson's disease. One hundred adults with Parkinson's will take either the supplement or a placebo for two years. Researchers will track movement, thinking, and blood markers to see if the supplement helps control the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEURO-DEGENERATIVE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Neuroscience Institute
Singapore, Singapore
-
Singapore General Hospital
Singapore, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Planning ahead: could a simple program transform Parkinson's care?
- Sound waves vs. Parkinson's: can ultrasound calm tremors and stiffness?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Could sharing lived experiences ease the burden of dementia care?
- Can we outsmart Gaucher's hidden toll on lungs, bones, and brain?